Changes in lymphocyte subsets after short-term pharmacotherapy in patients with panic disorder

Psychiatry Research

Volumn 128, Issue 2, 2004, Pages 183-190

  Kim, Youl Ri ^a   Park, Quehn ^b   Yu, Bum Hee ^a  

^a Sungkyunkwan University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

B lymphocytes; Drug therapy; Immunity; Panic disorder; T lymphocytes

Indexed keywords

ADRENALIN; ALPRAZOLAM; BIOLOGICAL MARKER; NORADRENALIN; PAROXETINE;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; B LYMPHOCYTE; CIRCULATION; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNE SYSTEM; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; NORADRENALIN BLOOD LEVEL; PANIC; PHENOTYPE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCORING SYSTEM; T LYMPHOCYTE;

ADULT; B-LYMPHOCYTE SUBSETS; DRUG ADMINISTRATION SCHEDULE; EPINEPHRINE; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; MALE; NOREPINEPHRINE; PANIC DISORDER; PAROXETINE; PERSONALITY INVENTORY; REFERENCE VALUES; SEROTONIN UPTAKE INHIBITORS; T-LYMPHOCYTE SUBSETS;

EID: 5644277614     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2004.05.015     Document Type: Article

References (33)

1. Abbas A.K., Lichtman A.H., Pober J.S. Cellular and Molecular Immunology. 2nd ed.:1994;WB Saunders, Philadelphia
2. Beck A.T., Ward C.H., Mendelson M., Mock J.E., Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry. 4:1961;561-571
3. Besedovsky H.O., del Rey A.E., Sorkin E., Da Prada M., Keller H.H. Immunoregulation mediated by the sympathetic nervous system. Cellular Immunology. 48:1979;346-355
4. Brambilla F., Bellodi L., Perna G., Battaglia M., Sciuto G., Diaferia G., Petraglia F., Panerai A., Sacerdote P. Psychoimmunoendocrine aspects of panic disorder. Neuropsychobiology. 26:1992;12-22
5. Charney D.S., Heninger G.R., Breier A. Noradrenergic function in panic anxiety: effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Archives of General Psychiatry. 41:1984;751-763
6. Charney D.S., Woods S.W., Krystal J.H., Nagy L.M., Heninger G.R. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients. Acta Psychiatrica Scandinavica. 86:1992;273-282
7. Coplan J.D., Tamir H., Calaprice D., DeJesus M., de la Nuez M., Pine D., Papp L.A., Klein D.F., Gorman J.M. Plasma anti-serotonin and serotonin anti-idiotypic antibodies are elevated in panic disorder. Neuropsychopharmacology. 20:1999;386-391
8. Felten D.L, Felten S.Y., Carlson S.L., Olschowka J.A., Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. Journal of Immunology. 135(2 Suppl.):1985;755s-765s
9. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders - Clinician Version (SCID-CV). 1997;American Psychiatric Press, Washington, DC
10. Hamilton M. The assessment of anxiety states by rating. British Journal of Medical Psychology. 32:1959;50-55
11. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry. 23:1960;56-62
12. Herbert T.B., Cohen S. Depression and immunity: a meta-analytic review. Psychological Bulletin. 113:1993;472-486
13. Jasnoski M., Bell I., Peterson R. What connections exist between panic symptoms, shyness, type I hypersensitivity, anxiety, and anxiety sensitivity. Anxiety, Stress, and Coping. 7:1994;19-34
14. Kennedy B.L., Morris R.L., Schwab J.J. Allergy in panic disorder patients: a preliminary report. General Hospital Psychiatry. 24:2002;265-268
15. Kohm A.P., Sanders V.M. Norepinephrine: a messenger from the brain to the immune system. Immunology Today. 21:2000;539-542
16. Liebowitz M.R., Fyer A.J., Gorman J.M., Dillon D., Appleby I.L., Levy G., Anderson S., Levitt M., Palij M., Davies S.O., Klein D.F. Lactate provocation of panic attacks: I. Clinical and behavioral findings. Archives of General Psychiatry. 41:1984;764-770
17. Manfro G.G., Pollack M.H., Otto M.W., Worthington J.J., Rosenbaum J.F., Scott E.L., Kradin R.L. Cell-surface expression of L-selectin (CD62L) by blood lymphocytes: correlates with affective parameters and severity of panic disorder. Depression and Anxiety. 11:2000;31-37
18. Marazziti D., Ambrogi F., Vanacore R., Mignani V., Savino M., Palego L., Cassano G.B., Akiskal H.S. Immune cell imbalance in major depressive and panic disorders. Neuropsychobiology. 26:1992;23-26
19. McDaniel J.S., Risby E.D., Stipetic M., Jewart R.D., Caudle J. Natural killer cell activity in patients with panic disorder. Anxiety. 1:1994;192-195
20. Nasciomento I., Nardi A.E., Valenca A.M., Lopes F.L., Mezzasalma M.A., Nascentes R., Zin W.A. Psychiatric disorders in asthmatic outpatients. Psychiatry Research. 110:2002;73-80
21. National Committee for Clinical Laboratory Standards Clinical Application of Flow Cytometry: Quality Assurance and Immunophenotyping of Peripheral Blood Lymphocytes. NCCLS documents H42-T. 1992;NCCLS, Villanova, PA
22. Rapaport M.H. Circulating lymphocyte phenotypic surface markers in anxiety disorder patients and normal volunteers. Biological Psychiatry. 43:1998;458-463
23. Reiss S., Peterson R.A., Gursky D.M., McNally R.J. Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behaviour Research and Therapy. 24:1986;1-8
24. Rosen F.S., Cooper M.D., Wedgwood R.J. The primary immunodeficiencies. New England Journal of Medicine. 311(2):1984;300-310
25. Sanders V.M., Straub R.H. Norepinephrine, the β-adrenergic receptor, and immunity. Brain, Behavior, and Immunity. 16:2002;290-332
26. Schleifer S.J., Keller S.E., Scott B.J., Vecchione J. Lymphocyte function in panic disorder. Biological Psychiatry. 27(Suppl. 9A):1990;66A
27. Schleifer S.J., Keller S.E., Bartlett J.A. Depression and immunity: clinical factors and therapeutic course. Psychiatry Research. 85:1999;63-69
28. Schleifer S.J., Keller S.E., Bartlett J.A. Panic disorder and immunity: few effects on circulating lymphocytes, mitogen response, and NK cell activity. Brain, Behavior, and Immunity. 16:2002;698-705
29. Schmidt-Traub S., Bamler K. Psychoimmunologischer zusammenhang zwischen allergien, panik unc agoraphobie. Qeitschrift für Klinische Psychologie, Psychopathologie und Psychotherapie. 40:1992;325-345
30. Sluzewska A., Rybakowski J.K., Laciak M., Mackiewicz A., Sobieska M., Wiktorowicz K. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Annals of the New York Academy of Sciences. 762:1995;474-477
31. Spielberger C.D., Gorsuch R., Lushene R., Vagg P., Facobs G. Manual for the State-Trait Anxiety Inventory, STAI (Form Y). 1983;Consulting Psychologists Press, Palo Alto
32. Stein M.B., Asmundson G.J. Autonomic function in panic disorder: cardiorespiratory and plasma catecholamine responsivity to multiple challenges of the autonomic nervous system. Biological Psychiatry. 36:1994;548-558
33. Wilkinson D.J.C., Thompson J.M., Lambert G.W., Jennings G.L., Schwarz R.G., Jefferys D., Turner A.G., Esler M.D. Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. Archives of General Psychiatry. 55:1998;511-520